Skip to main content
Clinical Trials/IRCT20200127046282N54
IRCT20200127046282N54
Recruiting
Phase 1

Safety and effectiveness of fibroblast-derived exosome injection in combination with minoxidil in patients with androgenic hair loss compared to minoxidil alone: ??a randomized clinical trial

Tehran University of Medical Sciences0 sites15 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Androgenetic alopecia.
Sponsor
Tehran University of Medical Sciences
Enrollment
15
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age 18 years and above and less than 45 years
  • Hamilton score 2 to 5 in male and female hair loss
  • Complete consent of the patient to participate in the plan

Exclusion Criteria

  • Patients with malignancy
  • Receiving chemotherapy in the last 5 years
  • Patients with sepsis
  • Pregnancy or breastfeeding
  • Active wound or infection at the treatment site
  • Receiving any topical or systemic medication in the last 3 months for hair loss

Outcomes

Primary Outcomes

Not specified

Similar Trials